Medtronic neurostimulation portfolio
This article was originally published in The Gray Sheet
Firm launches its SynergyPlus+ neurostimulation system, which allows patients to program up to 26 levels of chronic pain treatment, according to a June 15 release. The non-rechargeable, remote-controlled device gained approval through a PMA supplement in April. The product joins Medtronic's first-generation Synergy system and Restore rechargeable system. Indications include low back syndrome, degenerative disc disease, post laminectomy pain and unsuccessful disc surgery. Medtronic estimates 70 mil. people in the U.S. suffer from chronic pain...
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.